These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 25281527)

  • 1. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
    Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
    Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
    Lin Q; Sun X; Zhou N; Wang Z; Xu Y; Wang Y
    BMC Pulm Med; 2019 May; 19(1):98. PubMed ID: 31118007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: the results in a Chinese population.
    Yuan XS; Chen WC; Lin QR; Liu YJ; Zhu YY; Sun XJ; Wu QY; Liu JS; Xu YP
    J Thorac Dis; 2021 Mar; 13(3):1822-1832. PubMed ID: 33841971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
    Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
    Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.
    Dong B; Zhu X; Jin J; Chen Y; Ying H; Chen Y; Lu F; Shen W; Wang J; Chen M
    J Thorac Dis; 2020 Oct; 12(10):5934-5954. PubMed ID: 33209426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer.
    Kishi N; Matsuo Y; Menju T; Hamaji M; Nakakura A; Hanazawa H; Takehana K; Date H; Mizowaki T
    J Radiat Res; 2022 Sep; 63(5):758-771. PubMed ID: 35818291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
    Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
    Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
    Varlotto J; Fakiris A; Flickinger J; Medford-Davis L; Liss A; Shelkey J; Belani C; DeLuca J; Recht A; Maheshwari N; Barriger R; Yao N; DeCamp M
    Cancer; 2013 Aug; 119(15):2683-91. PubMed ID: 23605504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.
    Miyazaki T; Yamazaki T; Nakamura D; Sato S; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Surg Today; 2017 Dec; 47(12):1476-1483. PubMed ID: 28447170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer.
    Nakagawa T; Negoro Y; Matsuoka T; Okumura N; Dodo Y
    Respir Investig; 2014 Jul; 52(4):221-6. PubMed ID: 24998368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
    Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
    Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
    J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery.
    Palma D; Visser O; Lagerwaard FJ; Belderbos J; Slotman B; Senan S
    Radiother Oncol; 2011 Nov; 101(2):240-4. PubMed ID: 21775007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
    Kim D; Ferraris VA; Davenport D; Saha S
    South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.